NIH-Moderna investigational COVID-19 vaccine shows promise in mouse studies
Vaccine currently being evaluated in Phase 3 clinical testing.
Related Articles
Findings suggest COVID-19 rebound not caused by impaired immune response
Detailed analysis of eight patients published.
Potential treatment for rare autoimmune disorder adapted from CAR-T therapy
NIH-supported trial first step in developing new approach to treat myasthenia gravis.
Researchers find weaker immune response to viral infections in children with mitochondrial disorders
One of the first human studies on how mitochondrial function impacts immune cells to guide future treatments.
Biden-Harris Administration launches initiative to improve cancer outcomes in low-income areas
NIH effort will pilot programs addressing persistent poverty in the context of cancer
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people.
Long telomeres may heighten cancer risks
People with mutations that lead to excessively long chromosome tips, or telomeres, may be at increased risk for a range of cancers.
Sweet Trouble: How Sugar Intake Might Increase Alzheimer’s Risk – Neuroscience News
Researchers discovered a mechanism linking high sugar consumption to an increased risk of Alzheimer’s disease.
Blood vessel abnormalities in the eye could drive Alzheimer’s disease
Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer’s disease, according to research from Cedars-Sinai investigators published in the…
Large study provides scientists with deeper insight into long COVID symptoms
NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment.